treatment of vaginal stenosis resulting from pelvic radiation therapy . Community Oncology 2006 ; 3 : 665 – 671 . 80 Lindsey I George B Kettlewell M Mortensen N . Randomized, double-blind, placebo-controlled trial of sildenafil (Viagra) for
Search Results
The Challenges of Colorectal Cancer Survivorship
Crystal S. Denlinger and Andrea M. Barsevick
Edited by Kerrin G. Robinson
Patterns and Trends of Cancer Screening in Canada: Results From a Contemporary National Survey
Omar Abdel-Rahman
individuals with a confirmed cancer diagnosis. Cross-sectional studies may be more relevant to the assessment of adherence to different cancer screening programs. 7 The Canadian Community Health Survey (CCHS) is a cross-sectional study conducted annually and
Personalizing Medicine Through Personalized Communication: Individuality of the Patient Across Borders and Cultures
Giuseppe Curigliano
) coping with cancer through spirituality and community involvement. 1. The predominant sense of loss associated with breast cancer is a consistent theme for all women, across any latitude or longitude. This loss is both physical and emotional. Women
Racial Background and Health Behaviors Among Adults With Cancer in Canada: Results of a National Survey
Omar Abdel-Rahman
variable prevalence of different behaviors in different sectors of society. 1 , 9 – 13 The Canadian Community Health Survey (CCHS) is a national survey that has been conducted regularly on an annual basis. 14 It provides population
Low Provider Knowledge Is Associated With Less Evidence-Based Lung Cancer Screening
Jennifer A. Lewis, Heidi Chen, Kathryn E. Weaver, Lucy B. Spalluto, Kim L. Sandler, Leora Horn, Robert S. Dittus, Pierre P. Massion, Christianne L. Roumie, and Hilary A. Tindle
, pulmonology, hematology/oncology, and gynecology within an academic medical center (Vanderbilt University Medical Center [VUMC]) and its affiliated Veterans Health Administration (VHA), including hospital-based and community-based practices. VUMC has an
NCCN News
oncology with interests including lung cancer, esophageal cancer, and thoracic surgery. Dr. D'Amico remains active in the research community with a focus on the molecular biology of lung cancer and esophageal cancer and the genomic analysis of mutations. He
Social Determinants of Health and Racial Disparities in Cardiac Events in Breast Cancer
Nickolas Stabellini, Mantas Dmukauskas, Marcio S. Bittencourt, Jennifer Cullen, Amie J. Barda, Justin X. Moore, Susan Dent, Husam Abdel-Qadir, Aniket A. Kawatkar, Ambarish Pandey, John Shanahan, Jill S. Barnholtz-Sloan, Kristin A. Waite, Alberto J. Montero, and Avirup Guha
included all patients who had SDOH information available; patients without SDOH information were excluded. Demographic information from the catchment area, primarily based on US Census and American Community Survey data, was included to demonstrate the
Using the Science of Psychosocial Care to Implement the New American College of Surgeons Commission on Cancer Distress Screening Standard
Lynne I. Wagner, David Spiegel, and Timothy Pearman
be greatly expanded through integrating resources in the local community, such as Cancer Support Community sites, and nationally (eg, American Cancer Society, CancerCare, LIVESTRONG). Academic and high-volume cancer centers may have greater access
The Abu Dhabi Declaration: Why the Hustle?
Hamdy A. Azim, Abdul-Rahman Jazieh, and Mohammad Jahanzeb
approximately 15% of all cancer patients worldwide. Although this example shows its far-reaching benefit, it also shows that there is plenty of room for expanding its application. A real need exists within the oncology community to have a reliable evidence
The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?
Jagar Jasem, Christine M. Fisher, Arya Amini, Elena Shagisultanova, Rachel Rabinovitch, Virginia F. Borges, Anthony Elias, and Peter Kabos
classified into categories of 18 to 25 and 26 to 30. Cancer centers were divided according to the NCI classification into (1) community centers that treat 100 to 500 newly diagnosed cancer cases annually, (2) comprehensive community centers that treat ≥500